AMGN vs VSTD · P/E 24, rev $36.75B vs rev $12.8M
Amgen Inc (AMGN) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the AMGN and VSTD stock pages for the full models.
Not investment advice.